UNITED
      STATES


SECURITIES
      AND EXCHANGE COMMISSION


WASHINGTON,
      D.C. 20549




FORM
      10-KSB





(MARK
                ONE)x
            ANNUAL
                REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
                1934For
                the fiscal year ended October 31, 2005 ̈
            TRANSITION
                REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
                1934
                For the transition period fromto





Commission
      file number: 0-33229





Bio
      Solutions Manufacturing, Inc.


(NAME
      OF
      SMALL BUSINESS ISSUER IN ITS CHARTER)





New
                York
            16-1576984(STATE
                OR OTHER JURISDICTION OF
            (I.R.S.
                EMPLOYERINCORPORATION
                OR ORGANIZATION)
            IDENTIFICATION
                NO.1161
                James Street, Hattiesburg, Mississippi
            39401-4016(ADDRESS
                OF PRINCIPAL EXECUTIVE OFFICES)
            (ZIP
                CODE)





Issuer's
      telephone number: (601) 582-4000





Securities
      registered under Section 12(b) of the Exchange Act:


Title
                of each class
            Name
                of each exchange on whichregistered
                -------------------
            -----------------------------------------None
            None




Securities
      registered under Section 12(g) of the Exchange Act:


Common
      Stock, $.0001 par value


(TITLE
      OF
      CLASS)




Check whether the issuer (1) filed all reports required to be filed by Section
      13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
      period that the issuer was required to file such reports), and (2) has been
      subject to such filing requirements for the past 90 days. Yes x No  ̈





Check
      if there is no disclosure of delinquent filers in response to Item 405 of
      Regulation S-B contained in this form, and no disclosure will be contained,
      to
      the best of issuer's
      knowledge, in definitive proxy or information statements incorporated by
      reference in Part III of this Form 10-KSB or any amendment to this Form 10-KSB. x


-
          1
          -





Issuer's
      revenues for its most recent fiscal year (ended October 31, 2005): $
      206,085.




The
      aggregate market value of the voting and non-voting common equity held by
      non-affiliates of the issuer, based upon the price at which such common equity
      was sold on October 31, 2005, as reported by the OTC Bulletin Board, was
      approximately $4,977,702. Shares of common stock held by each officer and
      director and by each person who owns 5% or more of the outstanding common stock
      have been excluded in that such persons may be deemed to be affiliates. This
      determination of affiliate status is not necessarily a conclusive determination
      for other purposes.





The
      number of outstanding shares of the issuer's common stock on October 31, 2005,
      was 16,899,228.





Documents
      incorporated by reference: None.


Transitional
      Small Business Disclosure Format (CHECK ONE): Yes  ̈ No x


-
          2
          -




PART
      I


ITEM
      1.
      DESCRIPTION OF BUSINESS.





CORPORATE
      HISTORY. Bio Solutions Manufacturing, Inc. (the "Company") is a New York
      corporation that was formed on September 19, 1994. Prior to the fourth quarter
      of 2000, the Company operated under the name "Ream Printing Paper Corp." and
      had
      not engaged in any business for a number of years. From the fourth quarter
      of
      2000 until March, 2004, the Company operated under the name Single Source
      Financial Services Corporation (“SSFS”) and engaged in the electronic
      transaction processing business.





In
      March,
      2004, the Company acquired all of the issued and outstanding stock of Bio
      Solutions Manufacturing, Inc., a Nevada corporation, in exchange for
      approximately 92% of its issued and outstanding common stock. The Company
      changed its name to Bio Solutions Manufacturing, Inc. (“BSM”) and the name of
      its wholly owned subsidiary was changed to Bio Solutions, Production, Inc.
      (“BSP”). Through BSP, the Company is engaged in the business of manufacturing
      environmentally safe bio-remediation products for the treatment of various
      forms
      of waste by the food service industry and municipal waste treatment plants
      and
      other customers throughout the United States.





CURRENT
      BUSINESS. On January 27, 2004, the Company entered into a Reorganization and
      Stock Purchase Agreement and certain related agreements with Bio-Solutions
      Manufacturing, Inc. ("BSM") pursuant to which the Company agreed to issue
      11,865,000 shares of its common stock (which would constitute approximately
      92%
      of the Company's outstanding shares) to the shareholders of BSM in return for
      all of the outstanding shares of BSM (the "BSM Transaction"). BSM was a
      privately-held company that provides environmentally-safe solutions to
      restaurants, municipal waste treatment plants and other customers throughout
      the
      United States which are seeking environmentally-friendly forms of waste
      remediation.. In connection with the BSM Transaction, the parties agreed that
      certain other actions would be taken either prior to or after the closing,
      including (i) the transfer to Single Source Electronic Transactions, Inc.
      (“SSET”), a wholly owned subsidiary of SSFS, of all of the Company's shares in
      SSFS Merchant Services, Inc.(“ SSFSM”) and CardReady of New York, Inc.(“CRNY”),
      so that those entities became wholly- owned subsidiaries of SSET, (ii) the
      sale
      of all of the shares of SSET owned by BSM to the former control shareholders
      of
      SSFS for the payment of nominal consideration (iii) the Company's cancellation
      of its previous exercise of the CardReady Option and the transfer of the
      CardReady Option to SSET. Subject to the satisfaction of the conditions stated
      in the parties' agreements, the transaction was completed in March,
      2004.





Business
      Development




BSM is a technology provider of biological solutions to industries that desire
      environmentally-friendly forms of waste remediation. The Company (formerly
      known
      as Single Source Financial Services Corporation), is the parent of Bio Solutions
      Production, Inc. (“BSP”)(formerly known as Bio Solutions Manufacturing, Inc.), a
      Nevada corporation,


-
          3
          -


that
      was
      acquired in March, 2004 in exchange for 92% of the Company’s issued and
      outstanding stock. BSP is a biotechnology company, which owns intellectual
      properties for the construction and process of microbial products with remedies
      for certain environmental applications and production of value-added products.
      The Company’s products are sold through Bio Solutions Franchise Corp. (“BSFC”),
      an unrelated company. BSFC is a sales and marketing company for environmental
      application products that is currently building a network of franchises to
      sell
      and service certain applications while recruiting and training qualified
      distributors and strategic partners for the more complicated markets. BSFC
      owns
      the exclusive marketing rights for all of BSP's environmental related products.





The
      Company's principal place of business is 1161 James Street, Hattiesburg, MS
      39401 and its telephone number at that address is (601) 582-4000.





The
      Company is presently trading on the Over the Counter Bulletin Board ("OTCBB")
      under the symbol BSLM.





See
      (b)
      "Business of Registrant" immediately below for a description of the Company's
      business. Business of Registrant





GENERAL





Clogged
      drains can be a nasty and expensive problem in a residential setting. However,
      the problem is usually limited in its scope and remedied without reoccurrence.
      Conversely, in restaurants, groceries, hospitals and schools clogged drains
      are
      a never ending battle, which require a budget with no ceiling and downtime
      which
      can never be afforded. Many facilities use mechanical devices which merely
      bore
      a small hole which is still susceptible to plugging. Liquid products such as
      acids, caustics and solvents only open a small portion of the pipe temporarily.





As
      waste
      treatment becomes a more prominent industry, many organizations are exploring
      the possibilities of biological waste treatment. From clogged grease traps
      to
      industrial waste and sewage, companies are seeking the aid of a more natural
      treatment method.





Bacteria
      and enzymes have provided a method to accelerate nature's own bioremediation
      process. In the environment, both bacteria and enzymes play a part in
      biodegradation. Bacteria produce the enzymes essential for biometabolism. The
      enzymes then do their part to ease the metabolic reactions. The live microbes
      in
      these treatments actually eat the grease or other waste. These microbes continue
      to devour the grease or other waste as long as treatment is continued. These
      solutions are: cost-effective; environmentally friendly; low maintenance; and
      dependable. The solutions can: eliminate grease and fats; reduce Hydrogen
      Sulfide and ammonia levels; reseed bio-filters/plants; breakdown hydrocarbons;
      control odors; and improve sludge management. Areas in which the solutions
      have
      proved successful include: waste water treatment plants; sewer lines and lift
      stations; lagoons, holding tanks and aquaculture ponds; drain lines and grease
      traps; septic tanks, cesspools and drain fields.


-
          4
          -




The Company believes that its products and technology are more advanced than
      similar products on the market. BSFC has developed a franchise program to expand
      the end users to whom BSM’s products are ultimately sold.





PRINCIPAL
      PRODUCTS AND SERVICES





The Company's products have a combination of microbes and enzymes specifically
      selected, adapted and mixed in laboratories. These microbes have been designed
      to digest animal and plant tissues, proteins and cellulose. The formulation
      of
      the products has been developed to digest the waste products effectively and
      in
      an environmentally safe and responsible manner. This is based on several years
      of research and development work.





As
      soon
      as the microbes are activated by contact with any moisture, they go to work,
      break down targeted complex substances and convert them into simple, harmless
      and elemental substances. When the complex substances and compounds are digested
      and broken down into simpler elements, the noxious odors associated with (for
      example) sulfides, ammonia, nitrates and others are reduced or eliminated and
      simpler elemental substances flow out in the effluents. These effluents will
      have acceptable levels of BOD (Biological Oxygen Demand), TSS (Total Suspended
      Solids), FOG (Fats, Oil and Grease), etc., which thus become harmless.





The
      Company's primary products are the following:


Product
            
            PurposeBP
                - 310
            
            Treatment
                of Grease Traps/Lift Stations, primarily enzymatic
                reactionsBP
                - 710
            
            Treatment
                of Grease Traps/Lift Stations, primarily microbial
                actionsBP
                - 910
            
            Treatment
                of Portable ToiletsBP
                - 101
            
            Specific
                for Higher Carbohydrate ComplexBO
                - 102
            
            Specific
                for Higher Fats and OilsBuffer
            
            Balancing
                pHBio
                - Care H2S
            
            Specific
                for Hydrogen Sulfide ReductionBio
                - Care G
            
            Liquefies
                Hard Grease/FatBio
                - Care Wheels
            
            Cleans
                Grease and Dirt off the Wheels of Trolleys inRestaurantsBio
                - Care H & S (Hood & Stack)
            
            Degreases
                Hoods and Stacks in RestaurantsBio
                - Catalyst
            
            Enhances
                Activity of BP - 310 and BP - 710Bio
                - Care Lift Station
            
            For
                Odor ControlBio
                - Deplugger (for Drain Lines)
            
            For
                Blocked Drain LinesBio
                - Care F (Floor Soap)
            
            Cleans
                Grease and Dirt off Hard SurfacesECT
                - 2000
            
            Waste
                Water DisinfectantBio
                - Care Carpet Cleaner
            
            Cleans
                carpets of all types by removing dirt, grease and
                stainsBio
                - Care Oil and Grease
              Spot
                Cleaner
            
            Cleans
                oil, grease, and dirt build-up on hard surfaces of parking lots,
                garage
                floors, sidewalks, etc.Bio
                - Care Glass Cleaner
            
            Cleans
                oil, grease, dirt and many other spots on all glass
                surfaces





-
          5
          -


DEPENDENCE
      ON NEW PRODUCTS





The Company believes its ability to grow in its existing markets is partially
      dependent upon its ability to introduce new and innovative products into such
      markets. Although the Company seeks to introduce additional products each year
      in its existing markets, the success of new products is subject to a number
      of
      conditions, including developing products that will appeal to customers and
      comply with existing regulations at the time of introduction. There can be
      no
      assurance that the Company's efforts to develop innovative new products will
      be
      successful, that customers will accept new products, or that the Company will
      obtain regulatory approvals of such new products, if required. In addition,
      no
      assurance can be given that new products currently experiencing strong
      popularity and rapid growth will maintain their sales over time.





The
      products and services still in the research and development phase include the
      following:





Products
                under R & D
            Purpose----------------------------------------------------------------------------------------------------------------------------------------------------------------------
                Acquaculture
              Products
                for Cat
                Fish:                                                                                   
                To produce disease free and better quality cat fish moreeconomically.Acquaculture
                Products for Shrimp:
            To
                produce disease free & better quality shrimp more economically.Bio
                - Peel Gum
            Peels
                off chewing gum from the surface of concrete & similar areas.Bio
                - Care Algae
            To
                control algae in Ponds, Lakes, Golf Courses, etc.Bio
                - Care Hydrocarbons
            To
                treat contamination associated with petroleum & oil spills.





MANUFACTURING





The
      Company is manufacturing several biological products incorporating a combination
      of microbes and enzymes. These microbes have been specifically selected,
      adapted, dried and mixed in the Company's laboratories, located at 1161 James
      Street. The combinations have been designed to digest animal and plant tissues,
      proteins and cellulose. The formulations of the products have been developed
      to
      digest the waste products effectively and in an environmentally safe and
      responsible manner. This is based on several years of research and development
      work.





The
      Company's products break down complex waste products into simple, harmless
      and
      elemental substances. Depending upon the nature and concentration of the
      pollutants and other variables encountered, such as pH, time and temperature,
      appropriate additives are introduced to successfully complete the
      bio-augmentation process. When the complex substances and compounds are digested
      and broken down into simpler elements, the noxious odors associated with, for
      example sulfides, ammonia, nitrites and others are significantly reduced or
      eliminated and simpler elemental


-
          6
          -
 
  substances
        flow out in the effluents. Furthermore, the end product obtained by using
        the
        Company's products on dairy and hog lagoons proved to be a valuable soil
        fertilizer.








MARKETING,
      SALES AND DISTRIBUTION





MARKET




According
      to the research firm Environmental Business International, the overall
      environmental services industry grew at an annual rate of 2.7 percent in 1997
      to
      produce a total output of $186 billion. Approximately 117,000 U.S. companies
      are
      engaged in the business of environmental technologies of all kinds.





According
      to the research firm Business Communications Co., Inc., the market for
      wastewater bioremediation was $353 million in 1998 and was projected to grow
      to
      $374 million in 2001, an AAGR of 2.9%. The market for municipal solid waste
      management had a 1998 value of $237 million and was expected to be worth $262
      million in 2001, an AAGR of 5.1%. The conversion of waste-to-energy was a $66
      million sector of the bioremediation market in 1998 and was projected to account
      for $67 million in 2001, an AAGR of 0.8%.





BSFC
      plans to expand the sale of BSM’s products using franchising as its distribution
      approach. BSFC’s market position is best examined by reference to some of its
      direct franchising competitors. The following two (2) competitors claim they
      will have between thirty percent (30%) and one hundred percent (100%) growth
      in
      the number of franchises over the next year.





Direct
      franchise competitor, BioLogix® Systems Corporation, based in St. Louis,
      Missouri, claims to be a leader in the rapidly growing biotechnology and
      environmental service industry, widely known as "first" in innovation for waste
      (grease) elimination. Founded in 1989, this competitor currently had thirty-five
      (35) employees and revenue was $5 million in 1999 fiscal year and had nineteen
      (19) franchisees in twelve (12) states. BioLogix projects growth of twenty-two
      (22) more franchises in the next twelve (12) months.





Direct
      franchise competitor, Environmental Biotech, Inc., based in Sarasota, Florida,
      had $2.4 million of revenue in 1999. They claim to be the world leader in waste
      bioremediation technology. They started franchising in 1991 and have over
      sixty-six (66) franchises in the USA as well as master franchises and service
      sub-franchisees in Australia, Canada, Colombia, Japan, Malaysia, Mexico,
      Singapore, Slovenia and the United Arab Emirates.





UNITED
      STATES MARKET FOR ENVIRONMENTAL SERVICES





The
      Company operates in the environmental technology and services industry.
      According to the U.S. Industry and Trade Outlook 2000 published by the United
      States Department of Commerce, the environmental technologies and services
      industry includes air, water and soil pollution control; solid and toxic waste
      management; site remediation;


-
          7
          -
 
  engineering,
        design and consulting services; environmental monitoring; recycling; and
        industrial and clean process technology.





This
      mature industry has evolved in response to growing concern about the risks
      and
      costs of pollution and the enactment of pollution control legislation in the
      United States and around the world. The highly fragmented U.S. environmental
      industry is large and complex, consisting of both investor-owned and government
      entities that provide everything from small-scale consulting services to
      large-scale water utility operations.





According to Environmental Business International of San Diego, CA, the industry
      grew at an annual rate of 2.7% in 1997 to produce a total output of $186
      billion, up from $181 billion in 1996. The environmental sector's customers
      range from individual consumers, to locally regulated water utility monopolies
      and partnerships, to major U.S. corporations. Approximately 117,000 U.S.
      companies are engaged in the business of environmental technologies, with 4,300
      of those firms exporting internationally, generating $18.2 billion in export
      revenues and creating a trade surplus of $9.1 billion in 1997.





The
      research firm of Environmental Business International breaks the industry down
      even further into fourteen (14) segments of business activity which are divided
      into three (3) broad categories: services, equipment and resources. These
      environmental industry segments are classifications of types of businesses
      set
      out by the U.S. Standard Industry Classifications (SIC) system. Service revenues
      are those generated as fees paid for service, equipment revenues are sales
      of
      hardware and resources are sales of materials, water or energy. The Company
      primarily serves the "Remediation and Industrial Services" segment. This
      remediation segment in which the Company operates is estimated to generate
      approximately $12 billion a year in revenue.





THE
      BIOREMEDIATION MARKET SUB-SECTOR





According
      to the research firm Business Communications Co., Inc.("BCC"), municipal water
      treatment has relied on the use of microorganisms for many decades. Without
      biological contractors, trickling filters, or various kinds of digesters, it
      would be prohibitively expensive to purify municipal and commercial wastewater.
      Nearly sixty-five percent (65%) of the municipal waste generated in the U.S.
      each year (mainly paper, yard and food wastes) are considered easily
      biodegradable and therefore amenable to biological treatment. Another sixteen
      percent (16%) (rubber, leather, and plastic wastes) are considered "potentially
      biodegradable." That leaves only 19.2% (glass, metals, and miscellaneous) that
      are not potentially treatable with bioremediation. Currently, only about one
      percent (1%) of the total environmental management market is treated using
      bioremediation. Although this is a small percentage of the overall market,
      it
      represents over a billion dollar a year market sub-sector.





According
      to a recent BCC study titled "Bioremediation of Hazardous Wastes, Waste-water,
      and Municipal Waste," the value of the U.S. bioremediation market in 1998 is
      approximately $1.5 billion and is projected to increase to $1.76 billion in
      2001, reflecting an average annual growth rate ("AAGR") of five percent 5%.
      Predicted U.S. expenditures on


-
          8
          -
 
  biotechnology
        waste management are forecasted to increase annually through the turn of
        the
        century due to public involvement in environmental issues and corporate
        commitments to reduce the amount of toxic exposure in the environment. BCC
        notes
        that the biotechnology waste management market is led by the hazardous waste
        sector, which has benefitted from recent technological advances that have
        made
        it possible to biodegrade or otherwise treat a variety of hazardous wastes.
        This
        market was valued at $940 million in 1998 and is expected to increase to
        $1.05
        billion in 2001, an AAGR of six percent (6%).





The
      market for wastewater bioremediation was $353 million in 1998 and is projected
      to grow to $374 million in 2001, an AAGR of 2.9%. The market for municipal
      solid
      waste management had a 1998 value of $237 million and is expected to be worth
      $262 million in 2001, an AAGR of 5.1%. The conversion of waste-to-energy is
      a
      $66 million sector of the bioremediation market in 1998 and will account for
      $67
      million in 2001, an AAGR of 0.8%. Bio-enzymes are inherently environmentally
      preferable products. Since the products digest food waste and grease a little
      bit at a time, they prevent the need for acid-based chemicals, which can harm
      pipes and are disapproved by water treatment plants due to their caustic nature.
      Municipalities want food wastes reduced to carbon dioxide and water before
      they
      reach the treatment plants.





FRANCHISING
      DISTRIBUTION METHOD





The
      Company markets its products through BSFC which plans to grow using franchising
      as its distribution approach. The International Franchise Association ("IFA")
      estimates that franchising in the U.S. alone generated nearly $1 trillion in
      retail sales in the year 2000 and provides jobs for some 8 million Americans.





Franchising
      has evolved as a major means of business expansion in both American and
      international economies. Purchasing a franchise, which literally means "to
      be
      free," presents the opportunity and freedom for an investor to own and operate
      business with many immediate and long range advantages. Franchising is a
      marketing technique, or method of doing business, whereby a parent company
      (franchisor) grants (via a franchise agreement) an individual outlet owner
      (franchisee) the right to market its product and services while using the
      parent's name, reputation and marketing techniques.





FRANCHISE
      & SALES PROGRAM





BSFC
      was
      established in 1998 to market and sell environmental products and services.
      BSFC’s home office is located in Hattiesburg, Mississippi. In 1998, BSFC signed
      an agreement with Bio Solutions International (of which BSP was a division
      until
      March, 2004) to market and sell all of BSM's products on an exclusive basis.
      The
      products manufactured by BSP proved superior to other products on the market
      for
      targeting specific applications. BSP's ability to customize products for
      specific applications proved invaluable to BSFC's hands-on service approach
      to
      the market.





The
      franchise program is designed to be a comprehensive service using Company’s
      products for the treatment and prevention of:


-
          9
          -





A.
      Grease
      and related problems associated with the build up of grease and organics in
      grease traps, drain lines and toilets in cooking establishments such as
      restaurants, schools and nursing homes. The franchise is simply replacing the
      cost of pumping the grease traps and snaking the drain lines. The cost of
      treating the grease traps and drain lines with the Company’s products is
      normally much less than the conventional pumping and snaking method. The cost
      savings, elimination of the foul odors through accelerated bacteria
      decomposition, and the opportunity for the client to participate in the
      conservation of our environment offers little (if any) resistance to the sale.
      The Company treatment service has proved so successful the franchisee is able
      to
      guarantee the owner or manager that in the event there is a need to pump, he
      (the franchisee) will absorb the cost.





B. Municipal Waste Treatment Plants and Sewage Lift Stations: As real estate
      development and the industrial expansion continue at a rapid rate, the once
      remote locations of the municipal collection systems are now becoming surrounded
      with subdivisions, shopping centers and small businesses. The outcry to
      eliminate and control the pungent odors associated with these treatment plants
      is being exercised through lawsuits and community action groups at an alarming
      rate. The citizens are struggling with the foul odors and municipalities are
      struggling with the high and increasing cost of maintaining the lift stations
      and treatment plants because of the amount of grease released into the sewage
      conduits.





The
      Company’s bacteria has proven to be a very cost effective method of controlling
      odors and eliminating sewage waste associated with the treatment plants and
      maintaining the lift stations. This affords the franchisee an opportunity to
      work with the municipalities to address these problems and create a favorable
      environment to promote the use of these products for the restaurants, schools,
      nursing homes and other cooking establishments. The franchisee earns his income
      through the sale of products and the sale of his services that include the
      use
      of the Company’s products. The franchisee buys his products from BSFC.





COMPETITION





The
      principal markets in which the Company competes are competitive and fragmented,
      with competitors in the environmental services market and the bioremediation
      market sub-sector. Increased competition could have a material adverse effect
      on
      the Company, as competition may have far greater financial and other resources
      available to them and possess extensive manufacturing, distribution and
      marketing capabilities far greater than those of the Company. Although all
      future employees are expected to be required to sign confidentiality agreements,
      there is no guarantee either that trade secrets won't be shared with competitors
      or that the Company could enforce these agreements. Such disclosures, if made,
      could negatively affect the Company's competitiveness. The markets the Company
      serves are highly competitive and many competitors have much greater resources.
      Many of the competitors have substantially greater financial, technical and
      marketing resources, larger customer bases, longer operating histories, greater
      name


-
          10
          -
 
  recognition
        and more established relationships in the industry than Bio-Solutions
        International, Inc.





SOURCES
      AND AVAILABILITY OF RAW MATERIALS AND PRINCIPAL SUPPLIERS





The
      Company obtains all its raw materials for the manufacture of its products from
      other sources. The Company generally does not have contracts with any entities
      or persons committing such suppliers to provide the materials required for
      the
      production of its products. There can be no assurance that suppliers will
      provide the raw materials needed by the Company in the quantities requested
      or
      at a price the Company is willing to pay. Because the Company does not control
      the actual production of these raw materials, it is also subject to delays
      caused by interruption in production of materials based on conditions not wholly
      within its control. The inability of the Company to obtain adequate supplies
      of
      raw materials for its products at favorable prices, or at all, as a result
      of
      any of the foregoing factors or otherwise, could have a material adverse effect
      on the Company.





INTELLECTUAL
      PROPERTY





The Company’s products, formulas and processes are proprietary and owned it. The
      Company’s employees associated with and involved in any part of the
      research/manufacturing process have signed non-disclosure/confidentiality
      agreements in order to prohibit them from using any part of the technology
      developed and owned by the Company.





GOVERNMENTAL
      REGULATION





None.
      The
      Company's products are derived from naturally occurring bacteria and enzymes,
      which are environmentally friendly.





RESEARCH
      & DEVELOPMENT





The
      Company's products were developed based on several years of research work
      carried out in International Media and Culture laboratories at Salida, Colorado,
      followed by the work at Orchard and Superior, Nebraska Laboratories. After
      purchasing the technology from IMAC, the Company is strengthening different
      products through a research and development program with its facilities and
      research staff located permanently at its headquarters in Hattiesburg,
      Mississippi.





COMPLIANCE
      WITH ENVIRONMENTAL LAWS





Some
      municipalities have restrictions on enzyme use in grease traps. The Company
      uses
      bacteria and enzymes and has, to date, been able to obtain exemptions for such
      use.





PERSONNEL.


-
          11
          -





As
      of
      October 31, 2005, the Company had seven employees. Neither of the officers
      received compensation of any kind. The employees are not represented by a labor
      union for purposes of collective bargaining. The Company considers its relations
      with its employees to be excellent. The Company plans to employ additional
      personnel as needed.





ITEM
      2.
      DESCRIPTION OF PROPERTY.





The
      Company’s principal place of business is located at 1161 James Street,
      Hattiesburg, Mississippi, 39401, which it leases, by assignment from BSII,
      from
      an entity controlled by related parties. The lease will expire on April 30,
      2007
      with an annual rental of $36,000. The leased premises are approximately 12,000
      square feet of usable space. The Company uses the space both as its corporate
      headquarters and to manufacture and distribute its products. The term of the
      lease is for a period of five years. The Company owns no real property and
      its
      personal property consists of furniture, fixtures and equipment with a book
      value of $301,431 on October 31, 2005.





ITEM
      3.
      LEGAL PROCEEDINGS.





During
      the fiscal year ended October 31, 2003, the predecessor company (whose
      operations and results are not reflected in the operations of the Company),
      Arnold Sock and Martin Becker were defendants in litigation that had been filed
      by William Eisen and William Brown in Los Angeles County Superior Court on
      June
      27, 2001. The plaintiffs alleged that they were entitled to a finder's fee
      in
      the amount of $250,000 from the defendants in connection with the Company's
      acquisition of SSET The litigation was settled in November 2003 by the Company's
      payment of $5,000 in cash and the issuance of 14,000 shares of common
      stock.





ITEM
      4.
      SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.





No
      matters were submitted to security holders during the fiscal year ended October
      31, 2005.





PART
      II





ITEM
      5.
      MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.





MARKET
      INFORMATION. The Company's common stock is quoted on the OTC Bulletin Board
      under the symbol "BSLM." The following table sets forth the quarterly high
      and
      low bids for the Company's common stock as reported by the OTC Bulletin Board
      for the past two fiscal years:


-
          12
          -





Fiscal
                Year 2004
            
            High*
            
            Low*First
                Quarter
            
            $
            2.00
            
            $
            1.35Second
                Quarter
            
            $
            2.40
            
            $
            0.80Third
                Quarter
            
            $
            3.40
            
            $
            0.80Fourth
                Quarter
            
            $
            2.30
            
            $
            0.80Fiscal
                year 2005First
                Quarter
            
            $
            2.20
            
            $
            0.63Second
                Quarter
            
            $
            2.41
            
            $
            1.06Third
                Quarter
            
            $
            1.34
            
            $
            0.19Fourth
                Quarter
            
            $
            0.95
            
            $
            0.26





*
      These
      quotations reflect inter-dealer prices, without retail mark-up, mark-down or
      commission, and may not represent actual transactions.





SHAREHOLDERS.
      As of February 9, 2006, there were 1572 holders of record of the Company's
      common stock.





DIVIDEND
      POLICY. The Company has never declared or paid cash dividends on its common
      stock and anticipates that all future earnings, if any, will be retained as
      working capital and for business expansion. The payment of any future dividends
      will be at the sole discretion of the Board of Directors and will depend upon,
      among other things, the Company's future earnings, capital requirements and
      financial condition, as well as general business conditions. There can be no
      assurance that any cash dividends will ever be paid on the common stock.





RECENT
      SALES OF UNREGISTERED SECURITIES.





A
      resolution adopted on August 27, 2005, provided for the issue of 25,000 shares
      of restricted common stock to CA Reddy on joining the Company’s Technical
      Advisory Board and the issue of 25,000 shares per quarter, until a total of
      100,000 additional shares are issued to him. In accordance with the resolution,
      an additional 25,000 shares were issued to him on December 15,
      2005.





In
      August
      2005, the Company authorized the issue of 60,000 shares of the Company’s
      restricted common stock to Elliot Bates for services rendered by him in
      connection with leasehold improvements to the Company’s facility. These shares
      were issued December 15, 2005.





In
      January 2006, an additional 25,000 shares of restricted common stock were
      authorized to be issued to CA Reddy for his agreeing to become a member of
      the
      Company’s Technical Advisory Board. These shares have not yet been
      issued.





In
      January, 2006, the Company authorized the issue of 50,000 shares of its
      restricted common stock to each of its directors as compensation for services
      provided by


-
          13
          -
 
  them
        during the fiscal year ended October 31, 2005. A total of 200,000 shares
        will be
        issued. These shares have not yet been issued.





In
      January 2006, the Company authorized the issue of 100,000 shares of its
      restricted common stock to each of its officers as compensation for services
      rendered by them during the fiscal year ended October 31, 2005. A total of
      200,000 shares will be issued. These shares have not yet been issued.





ITEM
      6.
      MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.





THIS
      SECTION CONTAINS FORWARD-LOOKING STATEMENTS, INCLUDING STATEMENTS REGARDING
      THE
      COMPANY'S PROSPECTS FOR CONTINUED OPERATION AND EXISTENCE AND STATEMENTS
      REGARDING THE COMPANY'S PLANS, OBJECTIVES, EXPECTATIONS AND INTENTIONS. THOSE
      FORWARD-LOOKING STATEMENTS ARE BASED ON MANAGEMENT'S CURRENT EXPECTATIONS AND
      ARE SUBJECT TO A NUMBER OF RISKS, FACTORS AND UNCERTAINTIES THAT MAY CAUSE
      ACTUAL RESULTS, EVENTS AND PERFORMANCE TO DIFFER MATERIALLY FROM THOSE REFERRED
      TO IN THE FORWARD-LOOKING STATEMENTS. THOSE RISKS, FACTORS AND UNCERTAINTIES
      INCLUDE, BUT ARE NOT LIMITED TO, THE COMPANY'S HISTORY OF NET LOSSES,
      UNCERTAINTY AS TO THE AVAILABILITY OF REQUIRED FUNDING AND UNCERTAINTY AS TO
      THE
      COMPANY'S ABILITY TO MAINTAIN OPERATIONS AT ANY LEVEL. THE CAUTIONARY STATEMENTS
      MADE IN THIS SECTION SHOULD BE READ AS BEING APPLIED TO ALL RELATED
      FORWARD-LOOKING STATEMENTS WHEREVER THEY APPEAR IN THIS DOCUMENT.





QUALIFIED
      REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS. The Company's independent
      accountant has qualified his report, stating that the audited financial
      statements of the Company for the fiscal year ended October 31, 2004 and 2005
      have been prepared assuming the Company will continue as a going concern. The
      independent accountant notes that the Company's continued existence is dependent
      upon its ability to generate sufficient cash flows from operations to support
      its daily operations, as well as provide sufficient resources to retire existing
      liabilities and obligations on a timely basis.





RESULTS
      OF CONTINUING OPERATIONS FOR THE FISCAL YEARS ENDED October 31, 2005 AND October
      31, 2004.





REVENUES.
      Revenues from continuing operations for the fiscal year ended October 31, 2005
      were $ 206,085 and for the fiscal year ended October 31, 2004 were $191,372.The
      increase of $ 14,713, or 8% is due to increased product and service
      revenues.





COST
      OF
      REVENUES. Cost of revenue from continuing operations was $ 136,250 for the
      fiscal year ended October 31, 2005, a decrease of $ 4,799, or 3%, from the
      $141,029 for the fiscal year ended October 31, 2004.


-
          14
          -





GROSS
      PROFIT. The gross profit from continuing operations for the fiscal year ended
      October 31, 2005 was $ 69,836 and $50,343 for the fiscal year ended October
      31,
      2004. The increase of $ 19,493, or 39% is largely due to increased product
      and
      service revenues and decreased cost of goods sold.





SELLING,
      GENERAL AND ADMINISTRATIVE EXPENSES. The expenses for fiscal year ended October
      31, 2005 were $1,071,734 The Company's expenses increased by $415,803, up 63%
      during the fiscal year ended October 31, 2005, compared to 2004 levels of
      $655,931. The Company's higher expenses relative to increased operations and
      increased expenses related to being a public company.





NET
      LOSSES FROM CONTINUING OPERATIONS. The Company had a net loss of $1,024,683
      for
      the year ended October 31, 2005, as compared to $635,795 for the fiscal year
      ended October 31, 2004.





LIQUIDITY
      AND CAPITAL RESOURCES. As of October 31, 2005, the Company had cash of $ 982,
      and total current assets of $ 72,332 and total assets of $ 423,430. The
      Company's current and total liabilities were $1,256,383 as of October 31, 2005.
      Net funds for the year were provided by stock issued for services, $77,925,
      sale
      of common stock of $287,450, net loans of $528,018. Funds were used for the
      net
      loss (excluding depreciation and amortization) of $828,326, reduction in
      payables and accruals, $89,849 and higher accounts receivable of
      $48,682.





For
      the
      year ended October 31, 2004, the $31,472 increase in net funds were provided
      by
      sale of common stock $375,000, net loans, $783,888 and increases in payable
      and
      accruals of $151,740. Funds were used for net loss (excluding amortization
      and
      depreciation) of $514,059 and expenses for the acquisition and related costs
      of
      $734,339.








ITEM
      7.
      FINANCIAL STATEMENTS.





BAUM
      & COMPANY, P.A.


Certified
      Public Accountants


1515
      University Drive, Suite 226


Coral
      Springs, Florida 33071





REPORT
      OF INDEPENDENT
      REGISTERED PUBLIC ACCOUNTING FIRM





Board
      of
      Directors and Stockholders


Hattiesburg,
      Mississippi





We
      have
      audited the accompanying balance sheet of Bio Solutions Manufacturing, Inc.
      s of
      October 31,2005 and the related statements of operations, stockholders' equity
      (deficit) and cash flows for the years ended October 31, 2005 and 2004. These
      financial statements are the responsibility of the Company's management. Our
      responsibility is to express an opinion on these financial statements based
      on
      our audits.





We
      conducted our audits in accordance with the standards of the Public Company
      Accounting Oversight Board (United States). Those standards require that we
      plan
      and perform the audit to obtain reasonable assurance about whether the financial
      statements are free of material misstatement. An audit includes examining,
      on a
      test basis, evidence supporting the amounts and disclosures in the consolidated
      financial statements. An audit also includes assessing the accounting principles
      used and significant estimates made by management, as well as evaluating the
      overall financial statement presentation. We believe that our audits provide
      a
      reasonable basis for our opinion.





In
      our
      opinion, the financial statements referred to above present fairly, in all
      material respects, the financial position of Bio Solutions Manufacturing Inc.
      as
      of October 31, 2005 and the results of their operations and their cash flows
      for
      the years ended October 31, 2005 and 2004 in conformity with U.S. generally
      accepted accounting principles.





The
      accompanying financial statements have been prepared assuming that the Company
      will continue as a going concern. As discussed in Note 12, the Company is
      experiencing difficulty in generating sufficient cash flow to meet its capital
      requirements and sustain operations, which raises substantial doubt about its
      ability to continue as a going concern. The financial statements do not include
      any adjustments that might result from the outcome of this
      uncertainty.








/s/
      BAUM
& COMPANY, P.A.


BAUM
      & COMPANY, P.A.


Coral
      Springs, Florida


February
      16 2006








-
          15
          -








**Bio
                Solutions Manufacturing Inc.****Consolidated
                Balance Sheet****October
                31, 2005****ASSETS**CURRENT
                ASSETSCash
            
            $
            982Accounts
                Receivable-Affiliated Party
            
            
            48,682Inventory
            
            
            17,333Prepaid
                Expenses
            
            
            5,335Total
                current assets
            
            
            72,332PROPERTY
                AND EQUIPMENT (Net of accumulated depreciation of $ 174,115)
            
            
            306,431OTHER
                NON-CURRENT ASSETSProduct
                Formulation ( Net of $ 208,333 amortization)
            
            
            41,667Security
                Deposit
            
            
            3,000Total
                non-current assets
            
            
            44,667Total
                assets
            
            $
            423,430**LIABILITIES
                AND STOCKHOLDERS' DEFICIENCY**CURRENT
                LIABILITIESAccounts
                Payable and Accruals
            
            $
            375,473Loans
                Payable
            
            
            131,205Loan
                Payable -Related Party
            
            
            749,705Total
                Current Liabilities
            
            
            1,256,383Total
                Liabilities
            
            
            1,256,383STOCKHOLDERS'
                EQUITY (DEFICIENCY)Preferred
                Stock, no par value, 10,000,000 authorized,none
                issued and outstanding
            
            
            -Common
                stock $0.001 par value, 100,000,000 authorized,16,899,228
                shares issued and outstanding
            
            
            16,899Additional
                paid in capital
            
            
            1,383,654Accumulated
                Deficit
            
            
            (2,233,506
            )Total
                stockholders' equity (deficit)
            
            
            (832,953
            )Total
                liabilities and stockholders' equity
            
            $
            423,430The
                accompanying notes are an integral part of the financial statements.





-
          16
          -








**Bio
                Solutions Manufacturing Inc.****Consolidated
                Statement of Operations****For
                the Years ending October 31, 2005 and 2004****2005**
            
            **2004**REVENUESSales
                of franchises
            
            $
            -
            
            $
            12,501Product
                and service sales
            
            
            206,085
            
            
            178,871Total
                revenues
            
            
            206,085
            
            
            191,372COST
                OF GOODS SOLD
            
            
            136,250
            
            
            141,029Gross
                profit
            
            
            69,836
            
            
            50,343OPERATING
                EXPENSES
            
            
            1,071,734
            
            
            655,931Total
                operating expenses
            
            
            1,071,734
            
            
            655,931Net
                income (loss) before other income (expenses) andprovision
                for income taxes
            
            
            (1,001,898
            )
            
            (605,588
            )OTHER
                INCOME (EXPENSE)Interest
                income/(expense)
            
            
            (22,784
            )
            
            (30,207
            )Total
                other income (expense)
            
            
            (22,784
            )
            
            (30,207
            )Net
                income (loss) before provision for income taxes
            
            
            (1,024,683
            )
            
            (635,795
            )Provision
                for income taxes
            
            
            -
            
            
            -Net
                income (loss)-Continuing Operations
            
            
            (1,024,683
            )
            
            (635,795
            )(LOSS)
                FROM DISCONTINUED OPERATIONS
            
            
            -
            
            
            (20,756
            )Net
                income (loss)-Continuing Operations
            
            $
            (1,024,683
            )
            $
            (656,551
            )Net
                income (loss) per weighted average share-continuing operations
            
            
            ($0.06
            )
            
            ($0.05
            )Net
                income (loss) per weighted average share-discontinued operations
            
            $
            0.00
            
            
            ($0.00
            )Weighted
                average number of shares
            
            
            16,315,089
            
            
            14,001,287The
                accompanying notes are an integral part of the financial
                statements.




-
          17
          -





**Bio
                Solutions Manufacturing Inc****Consolidated
                Statement of Stockholders' Equity****Paid
                in Capital**
            
            **Accumulated**
            
            **Total****Number
                of**
            
            **Common**
            
            **Preferred**
            
            **in
                Excess**
            
            **Deficit**
            
            **Stockholders'****Shares**
            
            **Stock**
            
            **Stock**
            
            **of
                Par**
            
            
            
            **Equity**BALANCE,
                October 31, 200313,645,243
            
            $
                13,645
            
            $
                -
            
            $
                130,537
            
            $
                (573,028)
            
            $
                (428,846)March
                2004 common stock sold for $300.000
            150,000
            
            150
            
            
            
            299,850
            
            
            
            300,000April
                2004 $ 300,000 debt converted to 500,000 shares
            500,000
            
            500
            
            
            
            124,500
            
            
            
            125,000July
                2004 $ 5,000 debt converted to 20,000 shares
            20,000
            
            20
            
            
            
            4,980
            
            
            
            5,000-
            
            -
            
            
            
            -
            
            
            
            -October
                2004 common stock sold for $75,000
            150,000
            
            150
            
            
            
            74,850
            
            
            
            75,000Divestment
                of discontinued operations
            
            
            
            
            
            
            
            
            20,756
            
            20,756Net
                loss for the year ending October 31, 2004(656,551)
            
            (656,551)---------------
            
            ------------
            
            ------------
            
            ------------
            
            --------------
            
            --------------BALANCE,
                October 31, 2004
            14,465,243
            
            $
                14,465
            
            $
                -
            
            $
                634,717
            
            $
                (1,208,823)
            
            $
                (559,641)In
                November 2004, debt of $ 75,000 was converted into 300,000 shares
                of
                common stock.
            300,000
            
            300
            
            
            
            74,700
            
            
            
            75,000In
                November 2004, 100,000 shares of common stock were issued for $ 50,000.
            100,000
            
            100
            
            
            
            49,900
            
            
            
            50,000In
                December 2004, 1,243,985 shares of common stock were converted from
                debt
                of $ 310,996.
            1,243,985
            
            1,244
            
            
            
            309,752
            
            
            
            310,996In
                December 2004, 150,000 shares of common stock was issued for $ 75,000.
            150,000
            
            150
            
            
            
            74,850
            
            
            
            75,000In
                January 2005, 325,000 shares of common stock was issued for $
                155,000.
            325,000
            
            325
            
            
            
            154,675
            
            
            
            155,000In
                May 2005, 25,000 shares of common stock was issued for services worth
                $
                14,375.
            25,000
            
            25
            
            
            
            16,250
            
            
            
            16,275In
                June 2005, 40,000 shares of common stock was issued for services
                worth $
                9,840.
            40,000
            
            40
            
            
            
            9,800
            
            
            
            9,840In
                July 2005, 165,000 shares of common stock was issued for services
                worth $
                33,990.
            165,000
            
            165
            
            
            
            33,825
            
            
            
            33,990In
                August 2005, 60,000 shares of common stock was issued for services
                worth $
                17,820.
            60,000
            
            60
            
            
            
            17,760
            
            
            
            17,820In
                September 25,000 shares of common stock were issued for
                $7,450.
            25,000
            
            25
            
            
            
            7,425
            
            
            
            7,450Net
                loss for the year ending October 31, 2005(1,024,683)0BALANCE,
                October 31, 2005
            16,899,228
            
            16,899
            
            -
            
            1,383,654
            
            (2,233,506)
            
            191,730The
                accompanying notes are an integral part of the financial statements.





-
          18
          -




**Bio
                Solutions Manufacturing Inc.****Statement
                of Cash Flows****For
                the Years ending October 31, 2005 and 2004****2005**
            
            **2004**CASH
                FLOWS FROM OPERATING ACTIVITIES:Net
                income (loss)
            
            $
            (1,024,683
            )
            $
            (656,551
            )Adjustments
                to reconcile net income (loss) to netcash
                provided (used) by operations:Common
                stock issued for services
            
            
            77,925
            
            
            -Loss
                from Discontiued Operations
            
            
            -
            
            
            20,756Depreciation
                and amortization
            
            
            196,357
            
            
            142,452Changes
                in operating assets and liabilities:(Increase)
                decrease in accounts receivable
            
            
            (48,682
            )
            
            4,323(Increase)
                decrease in inventory
            
            
            7,871
            
            
            16,764(Increase)
                decrease in prepaid expenses
            
            
            (5,335
            )
            
            -Increase
                (decrease) in accounts payable and other accruals
            
            
            (89,849
            )
            
            151,740Increase
                (decrease) in accrued interest
            
            
            -
            
            
            -Increase/(decrease)
                in security deposits
            
            
            -
            
            
            (3,000
            )Net
                cash provided (used) by operating activities
            
            
            (886,396
            )
            
            (323,516
            )CASH
                FLOW FROM INVESTING ACTIVITIES:Expenses
                and cash used for acquistion
            
            
            -
            
            
            (734,339
            )Purchase
                of fixed assets
            
            
            -
            
            
            (64,574
            )Net
                cash provided (used) by investing activities
            
            
            -
            
            
            (798,913
            )CASH
                FLOW FROM FINANCING ACTIVITIES:Sale
                of common stock
            
            
            287,450
            
            
            375,000Payments
                of loans-other
            
            
            (55,000
            )
            
            (45,000
            )Proceeds
                from loans
            
            
            583,018
            
            
            828,888Bank
                overdraft
            
            
            4,987
            
            
            (4,987
            )Net
                cash provided (used) by financing activities
            
            
            820,455
            
            
            1,153,901Net
                increase (decrease) in cash
            
            
            (65,941
            )
            
            31,472CASH
                - BEGINNING
            
            
            66,923
            
            
            35,451CASH
                - ENDING
            
            $
            982
            
            $
            66,923SUPPLEMENTAL
                DISCLOSURE OF CASH FLOW INFORMATION:Cash
                paid for interest expense
            
            $
            -
            
            $
            -Cash
                paid for income taxes
            
            $
            -
            
            $
            -Stock
                issued to retire debt
            
            $
            385,996
            
            $
            -In
                Nov. & Dec. 2004, 1,543,985 shares of common stock were issued for
                debt conversion of $ 385,996.In
                November 2004, 100,000 shares of common stock were issued for $ 50,000.In
                December 2004, 150,000 shares of common stock were issued for $ 75,000.In
                January 2005, 325,000 shares of common stock were issued for $ 155,000.In
                2005, 290,000 shares of common stock were issued for services valued
                at $
                77,925.The
                accompanying notes are an integral part of the financial statements.





-
          19
          -


BIO
        SOLUTIONS MANUFACTURING, INC
 NOTES
        TO
        CONSOLIDATED FINANCIAL STATEMENTS
 October
        31, 2005
 
 Note
        1 -
        Summary of Significant Accounting Policies
 
 Nature
        of
        Business and History of Company
 
 Bio
        Solutions Manufacturing, Inc., ("BSM") (formerly named Single Source Financial
        Services Corporation until May 2, 2004) was incorporated in New York on
        September 19, 1994 under the name Ream Printing Paper Corp. In November 2000,
        the Company acquired Single Source Electronic Transactions, Inc. ("SSET").
        In
        March 1, 2004, it acquired Bio Solutions Production, Inc, (Production), formerly
        named Bio Solutions Manufacturing, Inc. a former manufacturing division of
        Bio
        Solutions International, Inc.
 
 Single
        Source Electronic Transactions, Inc. was in the business of selling equipment
        to
        merchants used in the electronically processing of payments derived from
        sales
        and assisting them in establishing merchant accounts with various financial
        institutions.
 
 In
        August
        2001, a dispute arose between the Company and the seller of SSET. Under the
        terms of the settlement, the seller received the historical residual stream
        generated on all sales made prior to July 31, 2001. For financial reporting
        purposes, the Company treated this transaction as a disposal of a business
        segment. After the settlement, the Company continued in the same business
        and in
        2002 discontinued the operations of SSET.
 
 The
        Company on March 1, 2004 commenced its manufacturing operations under its
        Bio-Solutions Production subsidiary. Bio-Solutions Manufacturing is a developer
        and manufacturer of biological waste remediation products, servicing municipal
        collection systems and food service facilities
 
 Basis
        of
        Presentation
 
 The
        accounting presentation reflects that Production as the acquiring entity,
        having
        been merged into the reporting company of SSET. The equity of SSET has been
        eliminated in consolidation, and all acquisition adjustments are reflective
        of
        Production
 
 Basis
        of
        Accounting
 
 The
        Company's financial statements are prepared using the accrual method of
        accounting.
 
 Property
        and Equipment
 
 Property
        and equipment are stated at cost. Major renewals and improvements are charged
        to
        the asset accounts while replacements, maintenance and repairs, which do
        not
        improve or extend the lives of the respective assets, are expensed. At the
        time
        property and equipment are retired or otherwise disposed of, the asset and
        related accumulated depreciation accounts are relieved of the applicable
        amounts. Gains or losses from retirements or sales are credited or charged
        to
        income.
 -
            20
            -
 
 The
        Company depreciates its property and equipment under the straight-line method
        as
        follows:
 
 Furniture    5
        years
 Office
        equipment                                 
5 years
 Machinery and
        equipment                 5
        years
 Leasehold
        improvements                  
10 years
 
 In
        August
        2001, SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived
        Assets," was issued establishing new rules and clarifying implementation
        issues
        with SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets and
        for
        Long-Lived Assets to be Disposed of," by allowing a probability weighted
        cash
        flow estimation approach to measure the impairment loss of a long-lived asset.
        The statement also established new standards for accounting for discontinued
        operations. Transactions that qualify for reporting in discontinued operations
        include the disposal of a component of an entity's operations that comprises
        operations and cash flow that can be clearly distinguished, operationally
        and
        for financial reporting purposes, from the rest of the entity. The Company
        has
        adopted this standard and its adoption had no significant effect on the
        Company's financial statements.
 
 Net
        Loss
        Per Share
 
 The
        Company adopted the provisions of Statement of Financial Accounting Standards
        ("SFAS") No. 128, "Earnings Per Share" ("EPS") that established standards
        for
        the computation, presentation and disclosure of earnings per share, replacing
        the presentation of Primary EPS with a presentation of Basic EPS.
 
 Cash
        and
        Cash Equivalents
 
 For
        purposes of the statement of cash flows, the Company considers cash and cash
        equivalents to include all stable, highly liquid investments with maturities
        of
        three months or less.
 
 Accounting
        Estimates
 
 Management
        uses estimates and assumptions in preparing financial statements in accordance
        with generally accepted accounting principles. Those estimates and assumptions
        affect the reported amounts of assets and liabilities, the disclosure of
        contingent assets and liabilities, and the reported revenues and expenses.
        Actual results could vary from the estimates that were used.
 
 Income
        Taxes
 
 The
        Company accounts for its income taxes under the provisions of Statement of
        Financial Accounting Standards 109 ("SFAS 109"). The method of accounting
        for
        income taxes under SFAS 109 is an asset and liability method. The asset and
        liability method requires the recognition of deferred tax liabilities and
        assets
        for the expected future tax consequences of temporary differences between
        tax
        bases and financial reporting bases of other assets and
        liabilities.
 
 -
            21
            -
 
 
 
 Fair
        Value of Financial Instruments
 
 Pursuant
        to SFAS No. 107, "Disclosures About Fair Value of Financial Instruments",
        the
        Company is required to estimate the fair value of all financial instruments
        included on its balance sheet as of October 31, 2005. The Company considers
        the
        carrying value of such amounts in the financial statements to approximate
        their
        face value.
 
 Revenue
        Recognition
 
 Revenue
        is recognized upon product shipment FOB.
 
 Principles
        of Consolidation
 
 The
        consolidated financial statements include the accounts of Bio Solutions
        Manufacturing, Inc. and its wholly owned subsidiaries Single Source Electronic
        Transactions, Inc. and Bio-Solutions Production Inc. All material inter-company
        accounts and transactions have been eliminated.
 
 Concentration
        of Risk
 
 The
        only
        customer for its products is Bio Solution Franchise Corp., which resells
        product
        primarily to its franchisees.
 
 Note
        2 -
        Loans Receivable and Payable - Discontinued operations
 
 The
        Company in accordance with the reorganization agreement merged with the
        predecessor company SSFS. As per the reorganization agreement, all previously
        existing loans receivable and payable were assumed by SSET and SSET was sold
        to
        the former control shareholders for $1.
 
 Note
        3 -
        Property and Equipment
 
 Depreciation
        charged to operations was $71,357
 
 At
        October 31, 2005 property and equipment consisted of the following:
 
 Office furniture and
        equipment                                       
$ 25,000
 Machinery and
        equipment                                                
205,546
 Leasehold
        improvements                                                  
250,000
 ------------
 480,546
 Accumulated
        Depreciation                                                               
(174,115)
 ------------
 Net
        Property and
        Equipment                                                           
$ 306,431
 ------------
 Note
        4 -
        Loan Payable
 
 Related
        Parties
 
 As
        of
        October 31, 2005, the Company has a balance due a related party of $749,705.
        The
        loan is currently non interest bearing, and has no maturity. Part of this
        loan
        is being repaid via product shipments. This loan is subject to the terms
        of a
        debt conversion agreement that the total outstanding balance, including prior
        accrued interest, is convertible into shares of common stock at a conversion
        price of $.25 per share at the option of the loan holder.
 -
            22
            -
 
 Loans
        Payable -
 
 As
        of
        October 31, 2005, the Company has loans payable of $76,205 that are non-interest
        bearing, has no maturity and is not collateralized.
 
 As
        a
        result of the asset purchase agreement dated March 18, 2004, a loan payable
        due
        to "BSII" was incurred for the unpaid balance of $100,000. The balance as
        of
        October 31, 2005 was $55,000. This unpaid balance is unsecured and non-interest
        bearing and is being repaid via product shipments.
 
 Note
        5 -
        Product Formula
 
 The
        Company as a result of the acquisition of manufacturing assets of Bio-Solutions
        International, Inc. had a step in value of its capitalized product formulas.
        Upon inception of the Company, a value of $50,000 was assigned to these assets
        as a result of a purchase from the outside party exclusively producing the
        product. Over the years, various costs for research and developments have
        been
        expensed to operations. Additionally, many new reformulations of the product
        have occurred and new products have been developed. As a result of the
        reorganization in March 2004, based on the consideration a value of $250,000
        was
        assigned to the product formulation. It has been ascertained, that the stated
        value of $250,000 for the product formulation will be amortized over two
        years.
        The amortization for the year ending October 31, 2005 was $125,000.
 
 Note
        6 -
        Discontinued Operations
 
 As
        indicated above, the Company transferred the residual stream of merchant
        accounts to the former owner of SSET. The Company accounted for this transaction
        as a disposal of a segment of its operations. Losses from discontinued
        operations for the year ended October 31, 2004 and 2005 was $ (20,756) and
        $0,
        respectively.
 
 Note
        7 -
        Stockholders' Equity
 
 Preferred
        Stock:
 
 As
        of
        October 31, 2005, the Company had authorized 10,000,000 shares of preferred
        stock. There were no shares issued or outstanding.
 
 The
        holders of preferred stock have certain preferential rights over the holders
        of
        the Company's common shares. Dividend features or voting rights are at the
        discretion of the Board of Directors without the requirement of shareholder
        approval.
 
 Common
        Stock
 
 As
        of
        October 31, 2005, the Company had authorized 100,000,000 shares of common
        stock
        of which 16,889,228 are issued and outstanding. The company was formerly
        the
        manufacturing division of "BSII". The assets and related assumed liabilities
        as
        a result of this acquisition of the manufacturing division formed the basis
        of
        the company's initial balance sheet along with the SSFS
        reorganization.
 
 The
        holders of the Company's common stock are entitled to one vote per share
        of
        common stock held.
 -
            23
            -
 
 In
        March
        1, 2004, 12,645,000 shares of common stock were issued for all of the common
        stock of Bio Solutions Production, Inc. ("Production"), formerly named Bio
        Solutions Manufacturing, Inc., a former division of Bio Solutions International,
        Inc. The Company replaced the warrants of "Production", with its warrants,
        expiring on January 31, 2007 to purchase the same number of the Company's
        common
        stock of 450,000 shares with similar terms.
 
 As
        part
        of the stock exchange, shareholders invested $667,600 in cash in "Production."
 
 In
        March
        2004, the company sold 150,000 shares of common stock for $2.00 per share
        and
        received $300,000. This was subsequently amended in July 2005, to $0.50 per
        share, and the $225,000 modification was recorded as a loan payable. This
        loan
        was assigned to a related party.
 
 On
        April
        7, 2004 $125,000 of debt was converted to 500,000 shares of common stock.
        On
        July 29, 2004, $5,000 of debt was converted to 20,000 shares of common
        stock.
 
 The
        Company issued 14,000 shares of its common stock in consideration for the
        settlement of a lawsuit that were valued at $14,000. See Note 11 for further
        details.
 
 In
        July
        2004, the Company converted $5000 of debt into 20,000 shares.
 
 In
        October 2004, the Company sold 150,000 shares for $75,000.
 
 In
        November 2004, the Company converted $125,000 of debt into 400,000
        shares.
 
 In
        December 2004, the Company converted $341,600 of debt into 1,243,985
        shares.
 
 In
        December 2004, the Company sold 150,000 shares for $75,000.
 
 In
        January 2005, the Company sold 325,000 shares for $155,000.
 
 In
        May
        2005, the Company issued 25,000 shares of stock for services valued at
        $16,275.
 
 In
        June
        2005, the Company issued 125,000 shares of restricted stock to three consultants
        for future services. Due to lack of performance by the consultants, the stock
        was rescinded in January 2006.
 
 In
        July
        2005, the Company issued 205,000 shares of stock for services valued at
        $$43,830.
 
 In
        August
        2005, the Company issued 60,000 shares of stock for services valued at $17,820.
        The Company also issued 400,000 shares of S-8 stock for services that was
        rescinded and reissued in January 2006 when technical deficiencies in the
        S-8
        authorization were corrected. An additional issuance of 150,000 shares of
        restricted stock issued in August 2005 for future services was rescinded
        in
        January 2006 when it was determined by the Board that the consultant was
        not
        performing the services.
 
 In
        September 2005, the Company issued 25,000 shares of stock for services valued
        at
        $7450.
 -
            24
            -
 
 All
        issuances of the Company's stock for non-cash consideration have been assigned
        a
        dollar amount equaling the market value of the shares issued on the respective
        stock issuance or the value of consideration received, whichever is more
        readily
        determinable. The market value has been determined by the Board to be 50%
        of the
        average closing price in the preceding five trading day for restricted stock
        and
        the average of the preceding five trading days for “free trading” stock, unless
        the amount of shares issued is greater than 0.5% of the company’s outstanding
        shares, as reported in the previous quarter’s SEC filings, then a discount of
        20% is recognized.
 
 Note
        8 -
        Subsidiary Acquisition
 
 On
        March
        18, 2004, the company, via a stock exchange, acquired the common stock of
        Bio
        Solutions Production, Inc. ("Production"), a former division of Bio Solutions
        International Inc. The net assets acquired include:
 
 Fixed
        Assets                            
$ 350,000
 Product
        Formulas                       
250,000
 Inventory                                       
41,968
 Payables                                    
(359,708)
 
 As
        part
        of the stock exchange, shareholders invested $667,600 in
        "Production"
 
 Note
        9 -
        Employee Stock Plan
 
 On
        April
        19, 2002, the Company formed the Bio Solutions Manufacturing Inc. (formerly
        Single Source Financial Services Corporation) 2002 Omnibus Securities Plan.
        Under the plan, the Company may grant options or issue stock to selected
        employees, directors, and consultants for up to 30,000 shares. The exercise
        price of each option is at the discretion of the Board of Directors but can
        not
        be less than 85% of the fair market value of a share at the date of grant
        (100%
        of fair market value for 10% shareholders). The vesting period of each option
        granted is also at the discretion of the Board of Directors, but each option
        granted shall vest at a rate of no less than 20% per year from date of
        grant.
 
 In
        August
        2005, the number of shares was increased by 3,000,000 and 400,000 shares
        were
        issued under the plan. In January 2006, the 3,000,000 increase was reaffirmed
        and ratified by the Board when technical deficiencies were corrected in the
        S-8
        authorization. As of October 31, 2005, the total authorization is 3,030,000
        shares, 23,950 shares have been issued and no options have been granted.
 
 Note
        10 -
        Income Taxes
 
 The
        provisions for income taxes for the year ended October 31, 2005 consisted
        of the
        following:
 
 Provision
        (benefit) for income
        taxes                             
$ 379,133
 at
        statutory federal rate,
 Valuation
        Allowance                                                        (379,133)
 ---------
 Net
        Income Tax
        Provision                                              
$           -
 =========
 -
            25
            -
 
 The
        reported provision for income taxes differs from the amount computed by applying
        the statutory U.S. federal income tax rate of 34% to the loss before income
        taxes as follows:
 
 October 31, 2005
 -------------------
 Federal
        income taxes at statutory
        rate                                        
34%
 State
        tax
        rate, net of federal income
        tax                                          3
 Valuation
        Allowance                                                                    
(37)
 ------
 Effective income tax
        rate                                                           0%
 ======
 
 Due
        to
        net operating losses and the uncertainty of realization, no tax benefit has
        been
        recognized for operating losses. The Company's ability to utilize its net
        operating loss carry forwards is uncertain and thus a valuation reserve has
        been
        provided against the Company's net deferred tax assets.
 
 At
        October 31, 2005 the Company has unused net operating losses of approximately
        $1,681,000 (which begin expiring in 2019) that may be applied, against future
        taxable income.
 
 Note
        11
        -Lease Commitments
 
 Effective
        March 1, 2004, the Company has assumed (from Bio Solutions International,
        Inc.)
        the net, net, lease for the office and warehouse facilities at its Bio Solutions
        Production, Inc. subsidiary for a term expiring in May 2007. Rent expense
        for
        the year ending October 31, 2005 was $50,993 which includes the real estate
        taxes required to be paid by BSM in addition to the base rent. Future minimum
        annual rentals are: 2006 $ 36,000 and 2007 $12,000. The leased facilities
        are
        owned by individuals that are considered related parties. It is ascertained
        that
        the Company is paying rent below the fair market value of real estate in
        its
        geographic area.
 
 Note
        12
        -Going Concern
 
 The
        accompanying financial statements have been prepared assuming that the Company
        will continue as a going concern. Going concern contemplates the realization
        of
        assets and the satisfaction of liabilities in the normal course of business
        over
        a reasonable length of time. The Company has incurred losses since inception
        and
        has negative cash flows from operations. For the year ended October 31, 2005
        the
        Company has incurred net losses of $ 1,024,683 and has accumulated losses
        of $
        2,233,506. The future of the Company is dependent upon its ability to obtain
        additional equity or debt financing and upon future successful development
        and
        marketing of the Company's product. Management is pursuing various sources
        of
        equity and debt financing. Although the Company plans to pursue additional
        financing, there can be no assurance that the Company will be able to secure
        such financing or obtain financing on terms beneficial to the Company. Failure
        to secure such financing may result in the Company's inability to continue
        as a
        going concern.
 -
            26
            -
 
 These
          financial statements do not include any adjustments relating to the
          recoverability and classifications of recorded assets, or the amounts and
          classification of liabilities that might be necessary in the event the
          Company
          cannot continue in existence.
 
 Note
          13-
          Stock Warrants
 
 As
          part
          of the cost of capital and loan acquisition, the company issued in the
          year
          ending October 31, 2005, 175,000 warrants at an average exercise price
          of $.86,
          expiring two years from issuance.
  As
          required by Statement of Financial Accounting Standards ( A SFAS @ )
          123,
          pro-forma information regarding net loss and loss per share has been determined
          as if the Company had accounted for its employee stock options and non
          employee
          warrants under the fair value method of that statement. The fair value
          for these
          options was estimated at the date of grant using a Black-Scholes option
          pricing
          model.
 
 The
          Black-Scholes option valuation model was developed for use in estimating
          the
          fair value of traded options that have not vesting restriction and are
          fully
          transferable. In addition, option valuation models require the input of
          highly
          subjective assumptions including the expected stock price volatility. Because
          the Company = s
          stock
          warrants have characteristics significantly different from traded options,
          and
          because changes in the subjective input assumptions can materially affect
          the
          fair value estimate, the existing models, in management = s
          opinion, do not necessarily provide a reliable single measure of the fair
          value
          of its stock options. Management believes that a reasonable value is $.01
          per
          warrant. The charge for warrants issued as part of the capital acquisition
          in
          the year ending October 31, 2005 would increase the loss by $ 1,750 or
          $ .00 per
          share for warrants valued at $.01 per warrant.
 
 A
          summary
          of the Company = s
          warrants issued as of October 31, 2004 and 2005, and changes during the
          years
          then ended is presented below:
 
 Year
          Ended October 31,
 2004                          
2005
 ----------------------------
 Weighted                    
          Weighted
 Average                       
Average
 Exercise                        
Exercise
 Shares      
Price           
Shares       Price
 ---------------------------------------------------------------------------------------------------------------------------------------
 Outstanding
          at beginning of
          Year                 
--     $
          ---               
450,000    $ 1.50
 Granted                                                        450,000   
          1.50             
175,000         .86
 Exercised                                                           --        
          --                        --             --
 Forfeited/Expired                                            
          --         --                        --             --
 ----------   
------            
----------     -------
 Outstanding
          at end of
          Year                    
450,000   $
          1.50             
625,000    $ 1.32
 =========
            =====       ========
 ======
 
 
 Note
          14-Recent Accounting Pronouncements
 
 The
          FASB
          recently issued the following statements:
 
 In
          November 2004, the FASB issued Statement of Financial Accounting Standards
          (SFAS) No. 151, Inventory Costs, which clarifies the accounting for abnormal
          amounts of idle facility expense, freight, handling costs, and wasted material.
          SFAS No. 151 will be effective for inventory costs incurred during fiscal
          years
          beginning after June 15, 2005. We do not believe the adoption of SFAS No.
          151
          will have a material impact on our financial statements.
 
 In
          December 2004, the FASB issued SFAS No. 153, Exchanges of Non-monetary
          Assets,
          which eliminates the exception for non-monetary exchanges of similar productive
          assets and replaces it with a general exception for exchanges of non-monetary
          assets that do not have commercial substance. We do not believe the adoption
          of
          SFAS No. 153 will have a material impact on our financial
          statements.
 
 In
          December 2004, the FASB issued SFAS No. 123(R), Share-Based Payment, which
          establishes standards for transactions in which an entity exchanges its
          equity
          instruments for goods or services. This standard requires a public entity
          to
          measure the cost of employee services received in exchange for an award
          of
          equity instruments based on the grant-date fair value of the award. This
          eliminates the exception to account for such awards using the intrinsic
          method
          previously allowable under APB Opinion No. 25. SFAS No. 123(R) will be
          effective
          for interim or annual reporting periods beginning on or after June 15,
          2005. We
          previously adopted the fair value recognition provisions of SFAS No. 123,
          Accounting for Stock-Based Compensation, on July 1, 2003 and have accounted
          for
          all awards granted to employees in recent years using the fair value recognition
          method. Accordingly we believe SFAS No. 123(R) will not have a material
          impact
          on financial statements.
 -
              27
              -


ITEM
      8.  CHANGES
      IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.





None.





ITEM
      8A.
      CONTROLS AND PROCEDURES.





The
      Company maintains disclosure controls and procedures that are designed to ensure
      that information required to be disclosed in the Company's Exchange Act reports
      is recorded, processed, summarized and reported within the time periods
      specified in the rules and forms of the Securities and Exchange Commission
      (the
      "SEC"), and that such information is accumulated and communicated to the
      Company's management, including its President and Chief Financial Officer,
      as
      appropriate,




-
          28
          -
 
  to
        allow
        timely decisions regarding required disclosure based on the definition of
        "disclosure controls and procedures" in Exchange Act Rules 13(a)-15(e) and
        15(d)-15(e). In designing and evaluating the disclosure controls and procedures,
        management recognizes that any controls and procedures, no matter how well
        designed and operated, can provide only reasonable assurance of achieving
        the
        desired control objectives, and management necessarily was required to apply
        its
        judgment in evaluating the cost-benefit relationship of possible controls
        and
        procedures. As of the end of the period covered by this report, the Company
        carried out an evaluation, under the supervision and with the participation
        of
        the Company's management, including the Company's President and Chief Financial
        Officer, of the effectiveness of the design and operation of the Company's
        disclosure controls and procedures. Based on the foregoing, the Company's
        President and Chief Financial Officer concluded that the Company's disclosure
        controls and procedures were effective. There have been no significant changes
        in the Company's internal controls or in other factors that could significantly
        affect those internal controls subsequent to the date the Company completed
        its
        evaluation.








PART
      III





ITEM
      9.  DIRECTORS,
      EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS; COMPLIANCE WITH SECTION
      16(a)
      OF THE EXCHANGE ACT.





DIRECTORS
      AND EXECUTIVE OFFICERS. The following table sets forth the names and ages of
      the
      current directors and executive officers of the Company and the principal
      offices and positions with the Company held by each person. Subject to prior
      resignation or removal, the Company's directors serve in that capacity until
      the
      next annual meeting of shareholders or until their successors are elected or
      appointed and duly qualified. Officers are appointed by the Board of Directors
      and serve in that capacity until resignation or removal.





Name
            Age
            PositionDavid
                S. Bennett
            66
            President
                and DirectorPatricia
                Spreitzer
            51
            Chief
                Financial Officer, Secretary and DirectorRobert
                J. Knorr, Jr
            
            DirectorMichael
                O’Gorman
            
            Director





DAVID
      S.
      BENNETT is the President/CEO of Bio-Solutions Manufacturing, Inc. Mr.
      Bennett has over 25 years experience in direct sales and channel partnerships,
      including IBM, Oracle and Sun Microsystems. Most recently, he has acted as
      senior business development consultant for a number of specialty start-up firms.
      He was Vice President and Head of North American Sales for OM Technology, Inc.,
      a European firm. He has generated over $50 million in software license revenues
      from treasury and derivative applications from over


-
          29
          -
 
  30
        banks
        and major financial institutions. From 1991 through 1997, as Head of Sales
        for
        TCAM, a North American firm specializing in order management and equities
        trading, Mr. Bennett brought the firm into the top 5% of software firms in
        the
        United States, based upon both license and service bureau revenue streams.
        He
        has both graduate and post graduate degrees in Economics and Education from
        Southampton University, U.K.





PATRICIA
      SPREITZER During the period from 2001 through 2003, Ms. Spreitzer had been
      employed as the assistant project controller for a publicly owned international
      general contractor. Prior and subsequent to such employment, she has been and
      is
      currently employed as an office manager responsible for all administrative
      functions including accounts receivable and accounts payable and
      payroll.





ROBERT
      J.
      KNORR, JR. has more than 40 years experience in various aspects of corporate
      and
      international marketing and finance. From 1968 until 1990, he was employed
      by
      Johnson and Johnson or its subsidiaries in various positions ranging from cost
      controller of a subsidiary to Vice-President of Finance for the Professional
      Sector of the Company. While employed by Johnson and Johnson, his
      responsibilities included the installation of a new standard cost system and
      provided the manufacturing departments with new and upgraded systems to better
      monitor operations, providing support to marketing in all aspects of finance,
      coordination of financial activities for 15 consumer and industrial companies,
      Chief Financial Officer of a 500 million dollar consumer products company where
      he directed all financial and information technology and established major
      cost
      improvement programs throughout the company generating at least 20 million
      dollars per year in savings and the negotiation of joint ventures in Russia
      and
      served as a consultant to the Vice Chairman for the professional sector. Since
      1990, Mr. Knorr, as a partner in Prism Consulting, has established a consulting
      company, found a new partner for Wrigley in Hungary and assisted other companies
      in the development of their business plans.





MICHAEL
      O’GORMAN received his Bachelor of Science in Organic Chemistry degree in August
      of 1976 from St. Peter’’s College, and completed his MBA in International
      Finance in August of 1979 from Fairleigh Dickenson University, Graduate School
      of Business, Madison, New Jersey. He also received his Juris Doctor in 1982
      from
      University of Connecticut at Bridgeport School of Law. For more than twenty
      years, he has provided legal, business and financial consulting services to
      numerous domestic and international companies. Mr. O’Gorman founded and
      incorporated EDS International, Inc.( Enviro Dynamic Systems, Inc.)(EDSI) in
      2002. The company designs and builds co-generation plants and incorporates
      unique and proprietary state-of-art designed ancillary profit centers of
      aquiculture and hydroponics farming utilizing the co-generation plant’s excess
      thermal energy.





FAMILY
      RELATIONSHIPS. There are no family relationships among any directors and/or
      executive officers of the Company.





LEGAL
      PROCEEDINGS. During the past five years, no bankruptcy petition has been filed
      by or against any business of which any executive officer, director, promoter
      or
      controlling shareholder of the Company was a general partner or executive
      officer either at the time of the bankruptcy or within two years prior to that
      time. In addition, during the past five years, no executive officer, director,
      promoter or controlling shareholder of the Company has been (i) convicted in
      a
      criminal proceeding or become subject to a pending criminal proceeding
      (excluding traffic violations and other minor offenses), (ii) subject to
      any


-
          30
          -
 
  order,
        judgment or decree, not subsequently reversed, suspended or vacated, of any
        court of competent jurisdiction, permanently or temporarily enjoining, barring,
        suspending or otherwise limiting such person's involvement in any type of
        business, securities or banking activities or (iii) found by a court of
        competent jurisdiction (in a civil action), the SEC or the Commodity Futures
        Trading Commission to have violated a federal or state securities or commodities
        law, and such judgment has not been reversed, suspended or vacated.





AUDIT
      COMMITTEE FINANCIAL EXPERT. The Company does not currently have an audit
      committee financial expert serving on it audit committee because its minimal
      level of operations does not create the need for such an expert.





COMPLIANCE
      WITH SECTION 16(a) OF THE SECURITIES EXCHANGE ACT OF 1934. Section 16(a) of
      the
      Securities Exchange Act of 1934 (the "Exchange Act") requires that the Company's
      directors and executive officers and persons who beneficially own more than
      ten
      percent of the Company's common stock file with the SEC initial reports of
      beneficial ownership and reports of changes in beneficial ownership of their
      common stock. Such executive officers, directors and significant shareholders
      are required by SEC regulations to furnish the Company with copies of all
      Section 16(a) reports that they file. To the Company's knowledge, based solely
      on a review of such reports and any amendments thereto furnished to the Company
      during or with respect to the fiscal year ended October 31, 2005, during such
      fiscal year none of such persons has failed to file on a timely basis any
      required Section 16(a) report.





CODE
      OF
      ETHICS. The Company does not intend to adopt a Code of Ethics until such time
      as
      its operations have increased from the current minimal levels and additional
      senior management personnel have been retained.





ITEM
      10.
      EXECUTIVE COMPENSATION.





EXECUTIVE
      OFFICERS AND DIRECTORS. None of the Company's officers are parties to employment
      agreements or other compensation arrangements with the Company. Compensation
      of
      $18,500 was paid to each of them during the last fiscal year. The directors
      did
      not receive any compensation of any kind from the Company for services provided
      during the last fiscal year. In January, 2006 the Company approved the issue
      of
      100,000 shares of restricted common stock to each of the officers and 50,000
      shares of restricted common stock to each of the directors for services provided
      by them during the last fiscal year. These shares have not yet been
      issued.





BOARD
      COMPENSATION. Directors of the Company receive compensation of $9,250 each
      for
      services provided as a director; they are also entitled to reimbursement for
      their travel expenses. The Company does not pay any amount for committee
      participation or special assignments of the Board of Directors.





ITEM
      11.  SECURITY
      OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
      MATTERS.


-
          31
          -





CERTAIN
      BENEFICIAL OWNERS. The following table sets forth the beneficial ownership
      of
      the Company's common stock (the Company's only class of voting stock) as of
      October 31, 2005 as to (i) each person or entity who is known by the Company
      to
      own beneficially more than five percent of the Company's common stock, (ii)
      the
      Company's directors and (iii) all directors and executive officers as a group.





Number
                ofSharesBeneficially
            
            Percentage
                ofBeneficial
                Owner
            
            Owned
                (1)
            
            Class(2)Bio
                Solutions Franchise Corp. (3)
            
            
            1,101,055
            
            
            6.52
            %Environmental
                Services of Mississippi, LLC (4)
            
            
            1,600,000
            
            
            9.47
            %Krish
                V. Reddy (5)
            
            
            1,000,000
            
            
            5.92
            %Sterling
                Sound, LLC (6)
            
            
            2,500,000
            
            
            14.79
            %Louis
                H. Elwell, III (7)
            
            
            1,419,247
            
            
            8.40
            %N.
                Wayne Wade (8)
            
            
            1,419,267
            
            
            8.40
            %All
                Directors and executive officers as a group (four persons) (9)
            
            
            82,000
            
            
            0.49
            %





(1)
      Beneficial ownership is determined in accordance with the rules of the SEC.
      In
      computing the number of shares beneficially owned by a person and the percentage
      ownership of that person, shares of common stock subject to options, warrants
      or
      similar rights held by that person that are exercisable on or before October
      31,
      2005 are deemed outstanding. Such shares, however, are not deemed outstanding
      for purposes of computing the percentage ownership of any other person. To
      the
      Company's knowledge, the persons named in the table have sole voting and
      investment power with respect to all shares of common stock shown as
      beneficially owned by them, subject to community property laws where applicable
      and the information contained in the footnotes to this table.





(2)
      Based
      on 16,899,228 shares of common stock outstanding.








(3)
      Address is 1161 James Street, Hattiesburg, Mississippi 39401





(4)
      Address is PO Box 16133, Hattiesburg, Mississippi 39403





(5)
      Address is 4124 W 4 th Street,
      Hattiesburg, Mississippi 39403





(6)
      Address is 606 Post Road East, #608, Westport, Connecticut 06880





(7)
      Address is P.O. Box 506, Long Branch, NJ 07764. Consists of 1,065,320 shares
      owned directly, 353,927 shares owned beneficially by Innovative
      Industries.


-
          32
          -





(8)
      Address is 1161 James Street, Hattiesburg, MS 39401. Consists of 585,340 shares
      owned directly, 480,000 shares owned beneficially as a member of Wades Farm,
      LLC
      and 353,927 shares owned beneficially by Innovative Industries.





(9)
      Consists of David S. Bennett, Patricia M. Spreitzer, Robert J. Knorr, Jr. and
      Michael O’Gorman. In January, 2006, the Company authorized the issue of 100,000
      shares of its restricted common stock to each of its officers and 50,000 shares
      of restricted common stock to each of its directors as compensation for services
      provided by them during the last fiscal year. These shares have not yet been
      issued.





EQUITY
      COMPENSATION PLANS. In April, 2002, the Company adopted the Single Source
      Financial Services Corporation 2002 Omnibus Securities Plan (the "Plan"). Under
      the Plan, the Company has available for issuance up to 3,000,000 shares of
      its
      common stock. The Plan was adopted to provide equity awards to (i) selected
      employees, directors and consultants of the Company in order to provide an
      opportunity to acquire a proprietary interest in the success of the Company,
      or
      to increase such interest, and to encourage those persons to remain in the
      employ of the Company and (ii) help attract new employees with outstanding
      qualifications. Under the Plan, the Company can make direct awards in the form
      of restricted shares of common stock or grant options to acquire those shares
      (which may constitute incentive stock options or non-statutory stock options).
      Of the 3,000,000 shares available for issuance under the Plan, 2,145,000 of
      those shares have previously been issued (although the issuance 250,000 of
      those
      shares was later cancelled). As a result of the 1 to 100 reverse split of the
      Company’s common stock, in October, 2003, only 6,050 shares remained available
      under the Plan. An amendment to the Plan was filed in August, 2005, which
      restored the number of shares authorized under the Plan to 3,000,000 shares.
      In
      August 2005, 400,000 shares were issued as compensation for professional
      services rendered to the Company and in January, 2006, 500,000 shares were
      issued to a consultant under the terms of a Consulting Agreement and 89,495
      for
      professional services. In January, 2006, the 3,000,000 share increase was
      reaffirmed and ratified by the Board of Directors wen technical deficiencies
      were corrected in the S-8 authorization. There are no outstanding warrants,
      warrants or other rights with respect to the issuance of any shares under the
      Plan. Neither the Company nor any of its subsidiaries (i) has issued any shares
      of the Company under any other equity compensation plan, including any
      individual compensation arrangement or (ii) currently has any shares of the
      Company authorized for issuance under any other equity compensation plan,
      including any individual compensation arrangement.





ITEM
      12.
      CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.





During
      the period from April, 2004 through December, 2004, the Company, under the
      terms
      of a Debt Conversion Agreement converted debt and accrued interest totaling
      $516,000 into 2,063,985 shares of common stock. The debt was incurred by the
      Company between October, 2001 and March 2002. The original creditor assigned
      her
      debt to unrelated third parties who subsequently converted the debt. At the
      time
      of each conversion, the debt converted had been held for more than two years,
      by
      an unaffiliated party. In reliance on the provisions of Rule 144, the shares
      were issued without restriction. The original creditor is an aunt of Tarun
      Mendiratta, president of Bio Solutions of Nevada, Inc., a franchisee of Bio
      Solutions Franchise Corp., the exclusive sales agent of the company’s products.
      Mr. Mendiratta provides advice and substantial support to the Company on an
      uncompensated


-
          33
          -
 
  basis
        and
        with his wife is the owner of a twenty percent membership interest in Sterling
        Sound, LLC, an affiliate of the company. Under the Limited Liability Company
        Operating Agreement, an unrelated third party is the managing member, with
        full
        control over the affairs of Sterling Sound.





The
      chief
      financial officer, who is also a director of the Company, is employed by Bio
      Solutions of Nevada, Inc., a franchisee of Bio Solutions Franchise Corp. Bio
      Solutions of Nevada, Inc.’s relationship to the Company is described
      above .





On
      July
      7, 2005, the Company entered into agreements with two related parties under
      the
      terms of which the creditors agreed to convert debt owed to them, totaling
      $220,000 into the Company’s Common Stock at the lesser of $0.25 per share or 20%
      below the 5 day trading average of the Company’s Common Stock for each dollar
      advanced plus interest at the rate of 71⁄2% per year from the date of the advance
      to the date of conversion.





The
      Company entered into an Agreement with a creditor on July 12  ,
      2005,
      to accept $225,000 of the Company’s product in repayment of the amount owed to
      it. The creditor assigned its right to receive the product to a franchisee
      of
      Bio Solutions Franchise Corp., the company that has the exclusive right to
      sell
      the company’s products. Under the terms of the Agreement, the amount due will be
      repaid in product to be selected by the franchisee in amounts not to exceed
      one-twelfth of the amount owed per month. The purchase price, which shall be
      the
      same price as product is sold to other franchisees, shall be paid by the Company
      to Bio Solutions Franchise Corp. either as a credit or as product. The price
      to
      be charged to Bio Solutions Franchise Corp. for the product shall be the same
      transfer price for the products paid by Bio Solutions Franchise corp. for
      products sold to other franchisees and shall be applied as an offset to the
      amount owed by Bio Solutions Manufacturing to Bio Solutions Franchise Corp.
      for
      product sold under the Agreement.





On
      July
      12, 2005, the Company entered into an agreement with a related party, who is
      also the owner of the franchise that will purchase the Company’s product under
      the Agreement referred to in the preceding paragraph, under the terms of which
      $57,500 of debt of the Company will be repaid in the Company’s product under the
      same terms as set forth in the preceding paragraph.





Three individuals who are beneficial owners of the Company’s stock provide
      informal advice to the Company. Tarun Mendiratta provides business, sales,
      investor relations and public relations consulting and fund raising services.
      The Company entered into a consulting agreement with Mr. Mendiratta for business
      strategy consulting and franchise promotion under the terms of which he received
      500,000 shares of the Company’s common stock under the 2002
      Omnibus Securities Plan, described above. N.
      Wayne
      Wade provides management consulting services in connection with the daily
      operation of the company’s plant and the marketing of the company’s products.
      Louis H. Elwell, III, provides administrative and marketing services to the
      Company. To date, there is no formal agreement for compensation. It is
      anticipated that one will be entered into.





-
          34
          -





ITEM
      13.
      EXHIBITS AND REPORTS ON FORM 8-K.


(a)
      Exhibits and Exhibit Index.


Exhibit
                No.
            
            Description-----------
            
            --------------------------------------------------------3.1
            
            Certificate
                of Incorporation, as amended, of the Company (1)3.2
            
            Bylaws
                of the Company (1)4.1
            
            Single
                Source Financial Services Corporation 2002 Omnibus Securities Plan
                (the
                "Plan") (2)4.2
            
            Form
                of Incentive Stock Option Agreement relating to options granted under
                the
                Plan (2)4.3
            
            Form
                of Non Statutory Stock Option Agreement relating to options granted
                under
                the Plan (2)4.4
            
            Form
                of Common Stock Purchase Agreement relating to restricted stock granted
                under the Plan (2)10.1
            
            Agreement
                between the Company and Sabita Dhingra dated October 3,
                2001(3)10.2
            
            Agreement
                between the Company and Onkar Holdings, Inc. dated October 3, 2001(3)
                10.3Agreement
                between the Company and Ardele (International) dated October 3, 2001(3)
                10.4Agreement
                between the Company and Sabaco Investment Advisors dated October
                3,
                2001(3)10.5
            
            Restated
                Letter of Intent dated April 29, 2002 by and between the Company,
                MBBRAMAR, INC. and CardReady International, Inc. (4)10.6
            
            Notice
                of Exercise of Option dated April 29, 2002 (4)Reorganization
                and Stock Purchase Agreement between the Company and Bio Solutions
                Production, Inc. (5)21
            
            Subsidiaries
                of the Company31.1
            
            Certification
                of Principal
                Executive Officer pursuant to Rule 13a-15(e) and 15d-15e of the Exchange
                Act31.2
            
            Certification
                of Principal
                Financial Officer pursuant to Rule 13a-15(e) and 15d-15e of the Exchange
                Act32.1
            
            Chief
                Executive Officer
                Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant
                to
                Section 906 of the Sarbanes-Oxley Act of2002.32.2
            
            Chief
                Financial Officer
                Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant
                to
                Section 906 of the Sarbanes-Oxley Act of
                2002.





--------------------


(1)
      Incorporated by reference from Company's Registration Statement on Form SB-2
      filed with the Commission on November 22, 2000 (File No. 333-50512).


(2)
      Incorporated by reference from Company's Registration Statement on Form S-8
      filed with the Commission on April 19, 2002 (File No. 333-86634).


(3)Incorporated
      by reference from Company's Registration Statement on Form S-8 filed with the
      Commission on October 9, 2001 (File No. 33-71222).


(4)
      Incorporated by reference from Company's Report on Form 8-K dated April 29,
      2002
      (File No. 0-33229).


(5)
      Incorporated by reference from Company's Report on Form 8-K filed April 2,
      2004
      (File No. 0471390).


(6)
      Incorporated by reference  from
      Company’s Report on Form 8-K, filed September 1, 2004 pursuant to Item 8


-
          35
          -


(7)
      Incorporated by reference from Company’s Report on form 8-K, filed October 27,
      2004 pursuant to Item 5.02


(8)
      Incorporated by reference from Company’s Report on Frm 8-K, filed January 11,
      2005 pursuant to Item 5.02


(9)
      Incorporated by reference from Company’s Report on Frm 8-K, filed January 11,
      2005 pursuant to Item 5.02 and 9.01


(10)
      Incorporated by reference from Company’s Report on Form 8-K, filed March 31,
      2005 pursuant to Items 1.01, 5.02 and 9.01


(11)
      Incorporated by reference from Company’s Report on Form 8-K/A, filed May 11,
      2005 pursuant to Item 9.01


(12)
      Incorporated by reference from Company’s Report on Form 8-K, filed June 15, 2005
      pursuant to Item 5.02


(13)
      Incorporated by reference from Form S-8 Registration Statement, filed August
      24,
      2005





(b)
      Reports on Form 8-K.


(1)
      Incorporated by reference from Company’s Report on Form 8-K, filed December 2,
      2005 pursuant to Item 4.02


(2)
      Incorporated by reference from Company’s Report on Form 8-K/A, filed January 3,
      2006 pursuant to Item 4.02





ITEM
      14.
      PRINCIPAL ACCOUNTANT FEES AND SERVICES.





FEE
      SUMMARY. The following is a summary of the fees billed to the Company by Baum
      and Company, LLC, for professional services rendered for the fiscal year ended
      October 31, 2005:





Fee
                Category
            
            Fiscal
                2005 Fees
            
            Fiscal
                2004 FeesAudit
                Fees (1)
            
            $
            20,000
            
            $
            17,500Audit-related
                Fees (2)
            
            $
            0
            
            $
            0Tax
                Fees (3)
            
            $
            0
            
            $
            0All
                Other Fees (4)
            
            $
            0
            
            $
            0TOTAL
                FEES
            
            $
            20,000
            
            $
            17,500





----------------





(1)
      Consists of fees billed for professional services rendered for the audit of
      the
      Company's consolidated financial statements and review of the interim
      consolidated financial statements included in quarterly reports and services
      that are normally provided by Baum and Company, LLC for the fiscal year ended
      October 31, 2005 in connection with statutory and regulatory filings or
      engagements.





(2)
      There
      were no audit-related services provided in fiscal 2005 or 2004.


-
          36
          -





(3)
      There
      were no tax-related services provided in fiscal 2005 or 2004.





(4)
      Other
      than the services reported above, there were no fees for products or services
      incurred in fiscal 2005 or 2004.





POLICY
      ON
      AUDIT COMMITTEE PRE-APPROVAL OF AUDIT AND PERMISSIBLE NON-AUDIT SERVICES OF
      INDEPENDENT AUDITORS. The policy of the Company's Audit Committee is to
      pre-approve all audit and permissible non-audit services provided by the
      independent auditors. These services may include audit services, audit-related
      services, tax services and other services. Pre-approval is generally provided
      for up to one year and any pre-approval is detailed as to the particular service
      or category of services and is generally subject to a specific budget. The
      independent auditors and management are required to periodically report to
      the
      Audit Committee regarding the extent of services provided by the independent
      auditors in accordance with this pre-approval, and the fees for the services
      performed to date. The Audit Committee may also pre-approve particular services
      on a case-by-case basis.














SIGNATURES





In
      accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused
      this report to be signed on its behalf by the undersigned, thereto duly
      authorized.





BIO
                SOLUTIONS MANUFACTURING, INC.Dated:
                March 2, 2006
            
            By:/s/
                David S. BennettDavid
                S. Bennett, President and DirectorIn
                accordance with the Exchange Act, this report has been signed below
                by the
                following persons on behalf of the registrant and in the capacities
                and on
                the dates indicated.Dated:
                March 2, 2006
            
            By:/s/
                Patricia M. SpreitzerPatricia
                M. Spreitzer, Secretary, Chief
              Financial
                Officer, and DirectorDated:
                March 2, 2006
            
            By:/s/ Robert KnorrRobert
                Knorr, Director








-
          37
          -